BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12195748)

  • 1. HER-2--a possible target for therapy of metastatic urinary bladder carcinoma.
    Wester K; Sjöström A; de la Torre M; Carlsson J; Malmström PU
    Acta Oncol; 2002; 41(3):282-8. PubMed ID: 12195748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of epidermal growth factor receptor and c-erbB-2 protein expression in transitional cell cancer of the upper urinary tract for tumour recurrence at the urinary bladder.
    Imai T; Kimura M; Takeda M; Tomita Y
    Br J Cancer; 1995 Jan; 71(1):69-72. PubMed ID: 7819052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor receptor status in breast cancer metastases to the central nervous system. Comparison with HER-2/neu status.
    Grupka NL; Lear-Kaul KC; Kleinschmidt-DeMasters BK; Singh M
    Arch Pathol Lab Med; 2004 Sep; 128(9):974-9. PubMed ID: 15335267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of HER2 expression in primary urinary bladder carcinoma and corresponding metastases.
    Gårdmark T; Wester K; De la Torre M; Carlsson J; Malmström PU
    BJU Int; 2005 May; 95(7):982-6. PubMed ID: 15839918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of epidermal growth factor receptor in urinary bladder cancer metastases.
    Bue P; Wester K; Sjöström A; Holmberg A; Nilsson S; Carlsson J; Westlin JE; Busch C; Malmström PU
    Int J Cancer; 1998 Apr; 76(2):189-93. PubMed ID: 9537579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder.
    Wright C; Mellon K; Johnston P; Lane DP; Harris AL; Horne CH; Neal DE
    Br J Cancer; 1991 Jun; 63(6):967-70. PubMed ID: 1712624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of Epidermal Growth Factor Receptor (EGFR) and HER-2 in Bladder Carcinoma and Its Association with Patients' Clinical Features.
    Li W; Wang Y; Tan S; Rao Q; Zhu T; Huang G; Li Z; Liu G
    Med Sci Monit; 2018 Oct; 24():7178-7185. PubMed ID: 30296252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of EGFR, HER2, HER3, and HER4 in metastatic squamous cell carcinomas of the oral cavity and base of tongue.
    Ekberg T; Nestor M; Engström M; Nordgren H; Wester K; Carlsson J; Anniko M
    Int J Oncol; 2005 May; 26(5):1177-85. PubMed ID: 15809707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential for molecular-targeted therapy targeting human epidermal growth factor receptor-2 for invasive bladder cancer.
    Yamada Y; Naruse K; Nakamura K; Aoki S; Taki T; Tobiume M; Zennami K; Katsuda R; Inoue Y; Noguchi H; Honda N
    Oncol Rep; 2007 Jul; 18(1):3-7. PubMed ID: 17549338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours.
    Fleischmann A; Rotzer D; Seiler R; Studer UE; Thalmann GN
    Eur Urol; 2011 Aug; 60(2):350-7. PubMed ID: 21640482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic breast carcinoma to the urinary bladder-a report of 11 cases including a tumor to tumor metastasis.
    Wang G; Zhou C; Conklin C; Hayes MM; Villamil CF; Ostry A; Jones EC
    Virchows Arch; 2019 Mar; 474(3):333-339. PubMed ID: 30607556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase III, Double-Blind, Randomized Trial That Compared Maintenance Lapatinib Versus Placebo After First-Line Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 1/2-Positive Metastatic Bladder Cancer.
    Powles T; Huddart RA; Elliott T; Sarker SJ; Ackerman C; Jones R; Hussain S; Crabb S; Jagdev S; Chester J; Hilman S; Beresford M; Macdonald G; Santhanam S; Frew JA; Stockdale A; Hughes S; Berney D; Chowdhury S
    J Clin Oncol; 2017 Jan; 35(1):48-55. PubMed ID: 28034079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Her-2/neu overexpression in muscle-invasive urothelial carcinoma of the bladder: prognostic significance and comparative analysis in primary and metastatic tumors.
    Jimenez RE; Hussain M; Bianco FJ; Vaishampayan U; Tabazcka P; Sakr WA; Pontes JE; Wood DP; Grignon DJ
    Clin Cancer Res; 2001 Aug; 7(8):2440-7. PubMed ID: 11489824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of epidermal growth factor receptor in invasive transitional cell carcinoma of the urinary bladder. A multivariate survival analysis.
    Nguyen PL; Swanson PE; Jaszcz W; Aeppli DM; Zhang G; Singleton TP; Ward S; Dykoski D; Harvey J; Niehans GA
    Am J Clin Pathol; 1994 Feb; 101(2):166-76. PubMed ID: 7906919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGFR and HER-2 status of non-small cell lung cancer brain metastasis and corresponding primary tumor.
    Koo JS; Kim SH
    Neoplasma; 2011; 58(1):27-34. PubMed ID: 21067263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical analysis of EGFR and HER-2 in patients with metastatic squamous cell carcinoma of the skin.
    Maubec E; Duvillard P; Velasco V; Crickx B; Avril MF
    Anticancer Res; 2005; 25(2B):1205-10. PubMed ID: 15865067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGFR, HER2 and HER3 expression in esophageal primary tumours and corresponding metastases.
    Wei Q; Chen L; Sheng L; Nordgren H; Wester K; Carlsson J
    Int J Oncol; 2007 Sep; 31(3):493-9. PubMed ID: 17671674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and immunohistochemical evaluation of epidermal growth factor receptor and c-erb-B-2 gene product in transitional cell carcinomas of the urinary bladder: a study in Greek patients.
    Gorgoulis VG; Barbatis C; Poulias I; Karameris AM
    Mod Pathol; 1995 Sep; 8(7):758-64. PubMed ID: 8539234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential of molecular targeted therapy of HER-2 and Cox-2 for invasive transitional cell carcinoma of the urinary bladder.
    Naruse K; Yamada Y; Nakamura K; Aoki S; Taki T; Zennami K; Katsuda R; Watanabe M; Nishikawa G; Itoh Y; Mitsui K; Hibi H; Honda N
    Oncol Rep; 2010 Jun; 23(6):1577-83. PubMed ID: 20428812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis.
    Lipponen P; Eskelinen M
    Br J Cancer; 1994 Jun; 69(6):1120-5. PubMed ID: 7911031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.